NASDAQ · Biotechnology

Eton Pharmaceuticals, Inc. (ETON) Stock

$54.75 -0.24% NASDAQ: ETON Healthcare

Valuation

MetricValue
Price$54.75
Market Cap$1.50B
P/E Ratio119.05
P/B Ratio32.85
P/S Ratio14.36
EPS (TTM)$-0.17
52-Week High$66.37
52-Week Low$14.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE40.13%
ROA10.96%
ROCE23.07%
Gross Margin0.00%
Operating Margin2.35%
Net Margin12.02%
Debt/Equity0.62
Current Ratio1.61

Annual Financials (USD)

Metric20212022202320242025
Revenue$22.0M$21.0M$32.0M$39.0M$80.0M
Operating Profit$-1.0M$-8.0M$-1.0M$-3.0M$0
Net Profit$-2.0M$-9.0M$-1.0M$-4.0M$-5.0M
EPS$-0.08$-0.36$-0.04$-0.15$-0.17
Op Margin-6.8%-38.9%-3.8%-6.7%0.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$27.0M$25.0M$32.0M$76.0M$92.0M
Total Liabilities$10.0M$12.0M$16.0M$52.0M$66.0M
Cash$14.0M$16.0M$21.0M$15.0M$26.0M
Borrowings$7.0M$7.0M$5.0M$30.0M$31.0M

Latest News

Eton Pharmaceuticals (ETON) Moves 13.8% Higher: Will This Strength Last? Zacks · Jul 20, 2026 Apple upgraded, Brinker initiated: Wall Street's top analyst calls The Fly · Jul 17, 2026 Canaccord Genuity Initiates Eton Pharmaceuticals at Buy With $60 Price Target MT Newswires · Jul 17, 2026 Eton Pharmaceuticals Insider Sold Shares Worth $1,623,795, According to a Recent SEC Filing MT Newswires · Jun 17, 2026 Eton Pharmaceuticals Insider Sold Shares Worth $3,229,923, According to a Recent SEC Filing MT Newswires · May 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$5.0M$7.0M$1.0M$11.0M
Investing Cash Flow$-6.0M$-6.0M$-2.0M$-40.0M$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-7.0M$2.0M$5.0M$-6.0M$11.0M
Free Cash Flow$-8.0M$2.0M$6.0M$1.0M$10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.16
EV / EBITDA81.80
FCF Yield0.97%
Quick Ratio1.30
Interest Coverage6.14
Return 1Y188.69%
Return 3Y1406.48%
Return 5Y584.49%

Ownership

Insiders Held5.32%
Institutions Held65.63%
Institutions Float Held69.32%
Institutional HolderSharesReport Date
Opaleye Management Inc.2,860,0002026-03-31
EcoR1 Capital, LLC2,171,9382026-03-31
Blackrock Inc.1,717,2862026-03-31
Nantahala Capital Management, LLC1,175,9512026-03-31
Vanguard Capital Management LLC994,0892026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DMACDiaMedica Therapeutics Inc. $8.01 +0.25% -11.43 $431.61M 0.00%
FENCFennec Pharmaceuticals Inc. $10.63 +2.61% -78.46 $369.25M 0.00%
IONSIonis Pharmaceuticals, Inc. $43.30 -1.95% -12.57 $7.20B 0.00%
LRMRLarimar Therapeutics, Inc. $2.70 -1.82% -1.49 $280.48M 0.00%
LXRXLexicon Pharmaceuticals, Inc. $1.76 +0.00% -12.10 $781.78M 0.00%

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. is led by CEO Sean E. Brynjelsen, employs 31 people, headquartered in US, publicly traded since 2018.

Eton Pharmaceuticals, Inc. (ETON) stock trades at $54.75 with a market capitalization of $1.50B. The stock is valued at a price-to-earnings (P/E) ratio of 119.05, price-to-book of 32.85, price-to-sales of 14.36. Over the past 52 weeks the stock has ranged between $14.27 and $66.37, and currently trades 17.5% below its 52-week high.

On profitability, Eton Pharmaceuticals, Inc. generates a return on equity (ROE) of 40.13% — well above the market average, a sign of a high-quality business, return on capital employed of 23.07%, an operating margin of 2.35%, a net profit margin of 12.02%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides